Research programme: granulocyte colony-stimulating factor mimetics - Affymax

Drug Profile

Research programme: granulocyte colony-stimulating factor mimetics - Affymax

Alternative Names: G-CSF mimetics research programme - Affymax; Gematide; Granulocyte colony-stimulating factor mimetics research programme - Affymax

Latest Information Update: 27 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Affymax
  • Class Peptides
  • Mechanism of Action Granulocyte colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Neutropenia

Most Recent Events

  • 20 Feb 2004 Preclinical trials in Neutropenia in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top